Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | C69 - Motor Neuron Disease

Tuesday 04/20/21
04:00 PM - 05:00 PM EDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Eva Feldman, MD, PhD, FAAN
Andrew J. Westwood, MD, FAAN
Neuromuscular and Clinical Neurophysiology (EMG)
Participants should become familiar with ALS environmental risk factors and ALS immune system mechanisms.
1.00 CME credit
Medical Knowledge
Introductory
Advanced Practice Provider
Specialist Neurologist
Didactic

Program Materials Program Evaluations

Event Timeline
04:00 PM - 04:25 PM EDT Speaker Environmental Exposures and ALS
Stephen Goutman, MD, FAAN
04:25 PM - 04:50 PM EDT Speaker Immune System Mechanisms in ALS
Eva Feldman, MD, PhD, FAAN
04:50 PM - 05:00 PM EDT Discussion Live Q&A
Eva Feldman, MD, PhD, FAAN, Stephen Goutman, MD, FAAN
Faculty Disclosures
Eva Feldman, MD, PhD, FAAN The institution of Dr. Feldman has received research support from National Institutes of Health. The institution of Dr. Feldman has received research support from Centers for Disease Control and Prevention / Agency for Toxic Substances and Disease Registry. The institution of Dr. Feldman has received research support from Juvenile Diabetes Research Foundation. Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Editorial Board Member with Journal of the Peripheral Nervous System, Experimental Neurology, Nature Neurology Reviews, Neurobiology of Disease, NeuroRx, Journal of Neurology Neurosurgery and Psychiatry, Scientific Reports, Lancet Neurology, Med (Cell Press Journal) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Editor-in-Chief with Oxford University Press Contemporary Neurology Series that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, and Chair of Section 07 with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Associate Editor with Annals of Neurology that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Governance Committee Chair with American Neurological Association that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, Chair of Section 07, Neuroscience Forum, Council Member with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Committee on Making ALS a Livable Disease Member with National Academy of Sciences, Engineering, and Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Member, Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) External Oversight Committee with National Institutes of Health that is relevant to AAN interests or activities.
Stephen Goutman, MD, FAAN Dr. Goutman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Evidera. The institution of Dr. Goutman has received research support from National Institutes of Health. The institution of Dr. Goutman has received research support from ALS Association. The institution of Dr. Goutman has received research support from CDC. Dr. Goutman has received intellectual property interests from a discovery or technology relating to health care.
Andrew J. Westwood, MD, FAAN Dr. Westwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia.